152 related articles for article (PubMed ID: 15033388)
1. Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies.
Hsiao G; Shen MY; Chou DS; Chang Y; Lee LW; Lin CH; Sheu JR
Eur J Pharmacol; 2004 Mar; 487(1-3):159-66. PubMed ID: 15033388
[TBL] [Abstract][Full Text] [Related]
2. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR
J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.
Sheu JR; Fong TH; Liu CM; Shen MY; Chen TL; Chang Y; Lu MS; Hsiao G
Br J Pharmacol; 2004 Sep; 143(1):193-201. PubMed ID: 15289295
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation.
Hsiao G; Wang Y; Tzu NH; Fong TH; Shen MY; Lin KH; Chou DS; Sheu JR
J Lab Clin Med; 2005 Oct; 146(4):216-26. PubMed ID: 16194683
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in the antiplatelet activity of midazolam in human platelets.
Sheu JR; Hsiao G; Luk HN; Chen YW; Chen TL; Lee LW; Lin CH; Chou DS
Anesthesiology; 2002 Mar; 96(3):651-8. PubMed ID: 11873041
[TBL] [Abstract][Full Text] [Related]
6. C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis.
Hsiao G; Chou PH; Shen MY; Chou DS; Lin CH; Sheu JR
J Agric Food Chem; 2005 Oct; 53(20):7734-40. PubMed ID: 16190625
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.
Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS
J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945
[TBL] [Abstract][Full Text] [Related]
8. Protective mechanisms of inosine in platelet activation and cerebral ischemic damage.
Hsiao G; Lin KH; Chang Y; Chen TL; Tzu NH; Chou DS; Sheu JR
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1998-2004. PubMed ID: 15976325
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory mechanisms of low concentrations of oxidized low-density lipoprotein on platelet aggregation.
Chou DS; Chan CH; Hsiao G; Shen MY; Tsai YJ; Chen TF; Sheu JR
J Biomed Sci; 2006 May; 13(3):333-43. PubMed ID: 16283430
[TBL] [Abstract][Full Text] [Related]
11. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
14. Na+/H+ exchange in PAF-stimulated platelets.
Borin ML; Pinelis VG; Azizova OA; Kudinov YV; Markov CM; Cragoe EJ; Khodorov BI
J Lipid Mediat; 1989; 1(5):257-72. PubMed ID: 2562435
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation.
Lee YM; Lee JJ; Shen MY; Hsiao G; Sheu JR
Eur J Pharmacol; 2006 May; 537(1-3):52-8. PubMed ID: 16624282
[TBL] [Abstract][Full Text] [Related]
16. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
17. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
Benjamin CW; Lin AH; Morris J; Wishka DG; Gorman RR
J Pharmacol Exp Ther; 1993 Apr; 265(1):457-62. PubMed ID: 7682615
[TBL] [Abstract][Full Text] [Related]
18. Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Hsiao G; Shen MY; Fang CL; Chou DS; Lin CH; Chen TF; Sheu JR
J Biomed Sci; 2003; 10(3):292-301. PubMed ID: 12711856
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: in vitro and in vivo studies.
Hsiao G; Lee JJ; Lin KH; Shen CH; Fong TH; Chou DS; Sheu JR
Cardiovasc Res; 2007 Sep; 75(4):782-92. PubMed ID: 17560560
[TBL] [Abstract][Full Text] [Related]
20. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
